Low intensity transcranial electrical stimulation safety has become a central topic as noninvasive brain stimulation rapidly expands across psychiatry, neurology, and consumer wellness. Techniques such as transcranial direct current stimulation and transcranial alternating current stimulation are now being studied for depression, anxiety, cognitive rehabilitation, chronic pain, and neurodevelopmental conditions. As use increases, clinicians and patients alike are asking an important question: how safe are these tools really?
A newly updated international guideline provides one of the most comprehensive answers to date, drawing on nearly a decade of additional data and hundreds of thousands of stimulation sessions.
What Is Low Intensity Transcranial Electrical Stimulation
Low intensity transcranial electrical stimulation, often shortened to tES, refers to a family of techniques that deliver very small electrical currents through electrodes placed on the scalp. These currents are far weaker than those used in electroconvulsive therapy and do not trigger seizures or loss of consciousness.
Common forms include transcranial direct current stimulation, which applies a constant low current, and transcranial alternating current stimulation, which delivers oscillating currents at specific frequencies. Other variations include random noise stimulation and newer approaches such as temporal interference stimulation. All aim to gently influence brain activity rather than force it.
What The New Safety Data Shows
The updated guideline reviewed safety data collected between 2017 and 2025, covering more than 300,000 stimulation sessions across healthy volunteers, psychiatric patients, neurological populations, and vulnerable groups. The findings are strikingly consistent.
No serious adverse events directly linked to tES were identified. Moderate side effects were rare and limited to specific experimental conditions. Most reported effects were mild and temporary, including tingling, itching, slight burning sensations at the electrode site, headaches, or fatigue. Importantly, many of these same sensations were also reported during sham or placebo stimulation.
These effects were similar across age groups, including children and older adults, and were not more frequent in people with psychiatric or neurological disorders.
Safety Across Devices, Settings, And Intensities
One of the most reassuring conclusions relates to dosage. Safety was well established for both bipolar and multichannel stimulation up to 4 milliamps and for daily sessions lasting up to 60 minutes. These parameters already exceed what many clinical and commercial devices currently use.
While fewer studies have explored higher intensities or longer durations, early data does not suggest a sudden increase in risk. Combined use with EEG monitoring, transcranial magnetic stimulation, or neuroimaging also did not introduce new safety concerns.
Home Based And Remote Supervised Use
Low intensity transcranial electrical stimulation safety is especially relevant as home based treatment models expand. Many protocols now rely on remote supervision, allowing patients to complete sessions outside the clinic while clinicians monitor adherence and side effects digitally.
The guideline notes that this shift has not been associated with increased adverse events when proper screening, training, and monitoring are in place. This finding supports the growing role of supervised at home neuromodulation as a way to improve access and consistency of care.
Ethical And Regulatory Considerations
Beyond physical safety, the authors emphasize ethical responsibility. Proper patient screening, informed consent, standardized training, and adverse event reporting remain essential. As devices become more accessible, clear regulatory frameworks are needed to prevent misuse and ensure evidence based application.
The guideline also calls for continued data collection, especially as researchers explore new stimulation patterns and longer treatment courses.
What This Means For Psychiatry And Patients
For interventional psychiatry, these findings reinforce that low intensity transcranial electrical stimulation is among the safest brain based interventions available today. When used responsibly, it offers a low risk option for research, clinical trials, and adjunctive care.
For patients, the message is equally important. Fear of brain stimulation often stems from confusion with older, more invasive treatments. The modern data tells a very different story, one grounded in careful monitoring, transparency, and global collaboration.
Citations
Antal A, Bjekić J, Ganho Ávila A, et al. Low intensity transcranial electric stimulation: Safety, ethical, legal, regulatory and application guidelines (2017–2025 update). Clinical Neurophysiology. 2025. https://pubmed.ncbi.nlm.nih.gov/41622107/
Bikson M, Grossman P, Thomas C, et al. Safety of transcranial direct current stimulation: Evidence based update. Brain Stimulation. 2016. https://pubmed.ncbi.nlm.nih.gov/26896183/